| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695551 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
A survival benefit may be achieved by consistently starting chemotherapy between 21 and 35Â days from primary debulking surgery. Women at higher risk for chemotherapy delay may be targeted for close follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Brandon-Luke L. Seagle, Sharlay K. Butler, Anna E. Strohl, Wilberto Nieves-Neira, Shohreh Shahabi,